Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt
I2 and thyroid
1 other identifier
observational
100
1 country
1
Brief Summary
Thyroxin a vital hormone for life lot of body functions depend on proper functioning on pituitary thyroid axis. it exists in two major forms Thyroxine (T4) and (T3) , each of them containing two iodine atoms on their inner (tyrosine) ring. Synthesis of reasonable quantities of thyroid hormones requires adequate iodine intake to allow sufficient thyroidal uptake. The World Health Organization (WHO) recommendation for daily intake of iodine is 150 μg for children ≥12 years and adults, and 250 μg for pregnant and lactating women. However as we know optimum amount of iodine is required for normal pituitary thyroid axis like wise excessive intake may cause over functioning of axis hence over production of hormone that can be manifested both clinically and biochemically. This study is designed to observe the frequency of over hyperthyroidism in patients taking iodinated salt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2021
CompletedFirst Posted
Study publicly available on registry
March 22, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedSeptember 22, 2021
September 1, 2021
5 months
March 16, 2021
September 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Affect of Iodinated Salt on Thyroid Status
Affect of Iodinated Salt on Thyroid Status
through study completion an average of 12 weeks
Eligibility Criteria
All patients presenting with biochemical hyperthythyroidism and taking Iodinated salt with age range of 18-60 years
You may qualify if:
- All patients presenting with biochemical hyperthyroidism
- Who are taking Iodinated salt.
- Treatment naïve patients
- Both genders included
- All patients who can give consent (18-60 years)
You may not qualify if:
- \) Pregnant females 2) Lactating mothers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mehwish Iftikhar
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 16, 2021
First Posted
March 22, 2021
Study Start
October 1, 2021
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
September 22, 2021
Record last verified: 2021-09